cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Dynavax Technologies Corporation
95 own
155 watching
Current Price
$0
$0.02
(0.17%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
1,512.12M
52-Week High
52-Week High
17.48
52-Week Low
52-Week Low
9.42
Average Volume
Average Volume
0.53M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization1,512.12M
icon52-Week High17.48
icon52-Week Low9.42
iconAverage Volume0.53M
iconDividend Yield--
iconP/E Ratio--
What does the Dynavax Technologies Corporation do?
Dynavax Technologies Corporation, a clinical-stage immunotherapy company, focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor (TLR) stimulation. Its product candidates are being investigated for use in multiple cancer indications, as a vaccine for the prevention of hepatitis B and as a disease modifying therapy for asthma. The company's lead product candidates include HEPLISAV-B, an investigational adult hepatitis B vaccine, which is in Phase III clinical trials; and SD-101, an investigational cancer immunotherapeutic that is in Phase I/II studies. Its product candidates also comprise AZD1419, which is in Phase II clinical trial for the treatment of asthma; DV230F that is in preclinical stage for the treatment of liver tumors; and DV1001, a TLR 7&8 agonist, which is in preclinical stage for the treatment of for multiple malignancies, as well as DV281 for the treatment of non-small cell lung cancer. It has collaboration and license agreements with AstraZeneca AB to develop AZD1419 for the treatment of asthma; and Merck & Co. to develop SD-101 for varios immuno-oncology therapies. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was founded in 1996 and is headquartered in Berkeley, California.
Read More
How much money does Dynavax Technologies Corporation make?
News & Events about Dynavax Technologies Corporation.
Benzinga
1month ago
Latest Ratings for DVAX DateFirmActionFromTo Dec 2021HC Wainwright & Co.MaintainsBuy Aug 2021HC Wainwright & Co.MaintainsBuy Aug 2021Goldman SachsInitiates Coverage OnBuy View More Analyst Ratings for DVAX View the Latest Analyst Ratings read more...
Globe Newswire
3 months ago
Saint-Herblain (France), March 2, 2023 Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced additional data from remaining clinical studies and an update on regulatory submissions for its inactivated COVID-19 vaccine, VLA2001. As previously announced, Valneva ...
Zolmax
3 months ago
Dynavax Technologies Co. (NASDAQ:DVAX Get Rating) Equities research analysts at William Blair issued their Q1 2024 earnings per share (EPS) estimates for Dynavax Technologies in a research report issued to clients and investors on Thursday, February 23rd. William Blair analyst M. Phipps forecasts ...
Globe Newswire
5 months ago
Saint-Herblain (France), December 30, 2022 Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today reported further heterologous booster data from an exploratory, small clinical study for its inactivated COVID-19 vaccine, VLA2001. In study VLA2001-3071, a subset of ...
Zolmax
5 months ago
Dynavax Technologies Co. (NASDAQ:DVAX Get Rating) Director Andrew A. F. Hack sold 1,500,000 shares of the stock in a transaction dated Tuesday, December 6th. The shares were sold at an average price of $11.60, for a total transaction of $17,400,000.00. Following the completion of the transaction, ...
Frequently Asked Questions
Frequently Asked Questions
What is Dynavax Technologies Corporation share price today?
plus_minus_icon
Can Indians buy Dynavax Technologies Corporation shares?
plus_minus_icon
How can I buy Dynavax Technologies Corporation shares from India?
plus_minus_icon
Can Fractional shares of Dynavax Technologies Corporation be purchased?
plus_minus_icon
What are the documents required to start investing in Dynavax Technologies Corporation stocks?
plus_minus_icon
What is today’s traded volume of Dynavax Technologies Corporation?
plus_minus_icon
What is today’s market capitalisation of Dynavax Technologies Corporation?
plus_minus_icon
What is the 52-Week High and Low Range of Dynavax Technologies Corporation?
plus_minus_icon
What percentage is Dynavax Technologies Corporation down from its 52-Week High?
plus_minus_icon
What percentage is Dynavax Technologies Corporation up from its 52-Week Low?
plus_minus_icon
Current Price
$0
$0.02
(0.17%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Axsome Therapeutics, Inc.
Axsome Therapeutics, Inc.
$75.59
$0.10 (0.13 %)
Viking Therapeutics, Inc.
Viking Therapeutics, Inc.
$24.88
$0.52 (2.13 %)
Adaptimmune Therapeutics plc
Adaptimmune Therapeutics plc
$1.00
$-0.04 (-4.02 %)
Ascendis Pharma A/S
Ascendis Pharma A/S
$92.28
$1.88 (2.08 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Axsome Therapeutics, Inc.
Axsome Therapeutics, Inc.
$75.59
$0.10 (0.13 %)
Viking Therapeutics, Inc.
Viking Therapeutics, Inc.
$24.88
$0.52 (2.13 %)
Adaptimmune Therapeutics plc
Adaptimmune Therapeutics plc
$1.00
$-0.04 (-4.02 %)
Ascendis Pharma A/S
Ascendis Pharma A/S
$92.28
$1.88 (2.08 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00